| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | CPN2 |
| Uniprot No | P22792 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 22-545aa |
| 氨基酸序列 | CPMGCDCFVQEVFCSDEELATVPLDIPPYTKNIIFVETSFTTLETRAFGSNPNLTKVVFLNTQLCQFRPDAFGGLPRLEDLEVTGSSFLNLSTNIFSNLTSLGKLTLNFNMLEALPEGLFQHLAALESLHLQGNQLQALPRRLFQPLTHLKTLNLAQNLLAQLPEELFHPLTSLQTLKLSNNALSGLPQGVFGKLGSLQELFLDSNNISELPPQVFSQLFCLERLWLQRNAITHLPLSIFASLGNLTFLSLQWNMLRVLPAGLFAHTPCLVGLSLTHNQLETVAEGTFAHLSNLRSLMLSYNAITHLPAGIFRDLEELVKLYLGSNNLTALHPALFQNLSKLELLSLSKNQLTTLPEGIFDTNYNLFNLALHGNPWQCDCHLAYLFNWLQQYTDRLLNIQTYCAGPAYLKGQVVPALNEKQLVCPVTRDHLGFQVTWPDESKAGGSWDLAVQERAARSQCTYSNPEGTVVLACDQAQCRWLNVQLSPQQGSLGLQYNASQEWDLRSSCGSLRLTVSIEARAAGP |
| 预测分子量 | 59.2 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于CPN2(Carboxypeptidase N亚基2)重组蛋白的3篇参考文献的简要信息，基于公开研究数据概括：
---
1. **文献名称**: *Recombinant Human Carboxypeptidase N2: Expression, Purification, and Functional Characterization*
**作者**: Smith J, et al.
**摘要**: 该研究报道了利用哺乳动物表达系统成功表达并纯化重组人CPN2蛋白，验证其酶活性(如降解缓激肽和补体过敏毒素C3a/C5a的能力)，并探讨其在炎症调控中的潜在应用。
2. **文献名称**: *Structural and Functional Analysis of CPN2 in Angioedema Pathogenesis*
**作者**: Lee S, et al.
**摘要**: 通过重组CPN2蛋白的晶体结构解析，揭示了其底物结合机制，并证明其在抑制血管性水肿中的作用，为开发相关治疗策略提供分子基础。
3. **文献名称**: *High-Yield Production of Recombinant CPN2 in Escherichia coli and Its Therapeutic Potential in Sepsis Models*
**作者**: Zhang R, et al.
**摘要**: 研究利用大肠杆菌系统高效表达CPN2重组蛋白，优化纯化工艺后，在脓毒症动物模型中验证其降低炎症因子水平、改善器官损伤的效果。
---
**注**：以上文献信息为模拟概括，实际文献需通过学术数据库(如PubMed、Web of Science)检索确认。建议结合具体研究方向补充关键词(如“重组表达”、“酶活性”、“疾病模型”)进一步筛选。
**Background of CPN2 Recombinant Protein**
Carboxypeptidase N subunit 2 (CPN2), also known as the regulatory subunit of carboxypeptidase N (CPN), is a critical component of the CPN enzyme complex. This complex, primarily circulating in plasma, plays a vital role in regulating bioactive peptides by cleaving terminal arginine or lysine residues from substrates such as kinins, anaphylatoxins (e.g., C3a, C5a), and fibrinopeptides. CPN2 binds to the catalytic subunit (CPN1) to stabilize the enzyme and modulate its substrate specificity. Dysregulation of CPN activity is linked to inflammatory diseases, cardiovascular disorders, and sepsis, highlighting its importance in homeostasis.
Recombinant CPN2 protein is produced using genetic engineering techniques, often expressed in mammalian or bacterial systems to ensure proper folding and post-translational modifications. Its recombinant form retains the ability to interact with CPN1. enabling functional studies on enzyme kinetics, inhibitor screening, and structural analysis. Researchers utilize CPN2 recombinant protein to investigate mechanisms underlying conditions like angioedema, hypertension, and immune dysregulation, as well as to develop therapeutic strategies targeting CPN activity.
Moreover, CPN2 serves as a biomarker in clinical diagnostics, with altered levels observed in liver diseases and systemic inflammation. The recombinant protein aids in standardizing assays to measure CPN activity or quantify CPN2 in patient samples. Advances in protein engineering have improved the stability and scalability of recombinant CPN2. facilitating its application in both basic research and drug discovery. Overall, CPN2 recombinant protein is a valuable tool for unraveling the physiological and pathological roles of the CPN complex.
×
